Anthony Rusk

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · Clinical Cancer Research · 2009 · 422 citations · Full text

Medicine, Oncology, Pharmacology +15

Intratumoral injection of <i>Clostridium novyi</i> -NT spores induces antitumor responses

Nicholas J. Roberts, Linping Zhang, Filip Jankú et al. · Science Translational Medicine · 2014 · 395 citations · Full text

Medicine, Microbiology, Oncology +13

Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors

Kevin A. Hahn, Legendre A.M., Shaw N.G. et al. · American Journal of Veterinary Research · 2010 · 82 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs with Naturally Occurring Cancers

Anthony Rusk, Evelyn McKeegan, Fortuna Haviv et al. · Clinical Cancer Research · 2006 · 77 citations

Medicine, Oncology, Pharmacology +13

Cooperative Activity of Cytotoxic Chemotherapy with Antiangiogenic Thrombospondin-I Peptides, ABT-526 in Pet Dogs with Relapsed Lymphoma

Anthony Rusk, Elizabeth Cozzi, Marty Stebbins et al. · Clinical Cancer Research · 2006 · 30 citations

Medicine, Oncology, Pharmacology +16